The Fight Against the Superbugs
Michaila Byrne for EMG GOLD writes about the rising threat of superbugs. The author investigates how the pharmaceutical industry and medical affairs teams can take action to combat and curb AMR in an effort to prevent a possible future superbug pandemic.
Taking into account the recent slowing of antibiotic development by pharmaceutical companies, the author looks into the reasons behind growing issues of antimicrobial resistance (AMR). Fatema Rafiqi, Research Programme Manager for the Antimicrobial Resistance Benchmark, is quoted in the article, noting the importance of support and funding in battling a possible future pandemic.